Balaji Ramraj

Dr. Balaji Ramraj

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
BRBalaji Ramraj
Balaji Ramraj
VSV. Meenakshi Subramanian
V. Meenakshi Subramanian
VGVijayakrishnan G
Vijayakrishnan G

20 April 2020 in Indian Journal of Community Health
Verified
Journal Article
Open access
PDF file
PKPraveen Kulkarni
Praveen Kulkarni
SPSudhir Prabhu
Sudhir Prabhu
SKSunil Kumar
Sunil Kumar
BRBalaji Ramraj
Balaji Ramraj
Coronavirus (COVID-19) is a humanitarian emergency. World Health Organization (WHO) and National Governments are making their best efforts to prevent the spread of disease. But a global epidemic of misinformation which is rapidly spreading through social media platforms and other outlets is posing serious problem to the public health interventions. This rapid spread of all sorts of information pertaining to the epidemic which makes its solution difficult is termed as infodemic. Infodemic creates fear, confusion and stigmatization among people and makes them more vulnerable to practice the measures which are not evidence based and scientifically sound. Hence there is an urgent need to identify the source of misinformation and prevent them from further spreading. WHO and the government of India have taken several steps in controlling this problem but there is a need for active involvement of social media companies, professional bodies, health care providers and general public in identification of misinformation and combating its spread.

18 May 2022 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
JRJeffrey Pradeep Raj
Jeffrey Pradeep Raj
SVShreeraam Venkatachalam
Shreeraam Venkatachalam
RARajkumar. S. Amaravati
Rajkumar. S. Amaravati
RBRamya Baburajan
Ramya Baburajan
AOAswathy Maria Oommen
Aswathy Maria Oommen
PMPhilip Mathew
Philip Mathew
Background: Undergraduate medical students in India participate in various research activities However, plagiarism is rampant, and we hypothesize that it is the lack of knowledge on how to avoid plagiarism. This study’s objective was to measure the extent of knowledge and attitudes towards plagiarism among undergraduate medical students in India. Methods: It was a multicentre, cross-sectional study conducted over a two-year period (January 2018 – December 2019). Undergraduate medical students were given a pre-tested semi-structured questionnaire which contained: (a) Demographic details; (b) A quiz developed by Indiana University, USA to assess knowledge; and (c) Attitudes towards Plagiarism (ATP) questionnaire. Results: Eleven medical colleges (n = 4 government medical colleges [GMCs] and n = 7 private medical colleges [PMCs]) participated. A total of N = 4183 students consented. The mean (SD) knowledge score was 4.54 (1.78) out of 10. The factors (adjusted odds ratio [aOR]; 95% Confidence interval [CI]; p value) that emerged as significant predictors of poor knowledge score were early years of medical education (0.110; 0.063, 0.156; < 0.001) and being enrolled in a GMC (0.348; 0.233, 0.463; < 0.001).The overall mean (SD) scores of the three attitude components namely permissive, critical and submissive norms were 37.56 (5.25), 20.35 (4.20) and 31.20 (4.28) respectively, corresponding to the moderate category. Conclusion: The overall knowledge score was poor. A vast majority of study participants fell in the moderate category of attitude score. These findings warrant the need for incorporating formal training in the medical education curriculum.


15 May 2025 in Journal of Infection
Verified
Journal Article
Open access
BDBella Devaleenal Daniel
Bella Devaleenal Daniel
SSSivakumar Shanmugam
Sivakumar Shanmugam
RMRashi Mehta
Rashi Mehta
MBManpreet Bhalla
Manpreet Bhalla
MMMuthuvijayalakshmi Mariappan
Muthuvijayalakshmi Mariappan
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini
Assess the effectiveness of bedaquiline, pretomanid and linezolid (BPaL) regimens with varying doses and duration of linezolid at the end of 48 weeks post treatment among drug resistant tuberculosis (DR TB) patients. Multicentric pragmatic randomized clinical trial in which BPaL regimens were given for 26 weeks for pulmonary pre extensively drug resistant tuberculosis (PreXDR TB); bedaquiline, pretomanid and linezolid 600 mg for 26 weeks (arm1), structured dose reduction arms with linezolid dose reduction from 600 to 300 mg after nine weeks (arm2) and 13 weeks (arm3). Participants were followed up for recurrence-free cure up to 48 weeks post-treatment. Whole genome sequencing in sputum samples at baseline and recurrence differentiated relapse and reinfection. Of 403 enrolled, 378 were included for the modified intent-to-treat analysis based on baseline sputum culture positivity and sensitivity to medications in the study regimen. Among them, 331(88%) had recurrence-free cure at the end of 48 weeks of post-treatment follow-up; arm1:112(87%), arm2:110(88%), arm3:109(88%). Overall, 14 (12 bacteriological and 2 clinical) recurrences (arm1-four, 2-six and 3-four) occurred; 11 recurrences occurred within 24 weeks after treatment completion; four out of 11 within the first 12 weeks. Of the 10 paired sputum samples available at baseline and recurrence for comparison of lineages, there were two reinfections and eight relapses. Structured dose reduction arms had comparable recurrence free cure rates as linezolid 600 mg arm when given along with bedaquiline and pretomanid for 26 weeks in PreXDR TB. Most of the recurrences occurred within the first six months.

Verified
Journal Article
Open access
PDF file
BRBalaji Ramraj
Balaji Ramraj
KNKarikalan Nagarajan
Karikalan Nagarajan
DPDebjani Ram Purakayastha
Debjani Ram Purakayastha
MMMajor Madhukar
Major Madhukar
MKMakesh Kumar
Makesh Kumar
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini
Evidence on the implementation aspects of nutritional support interventions for persons with TB in India is limited. This qualitative study employed focus group discussions with persons with TB (n = 71), their family caregivers (n = 17), and healthcare providers (n = 18). The study was conducted from August 2023 to April 2024 in five states in India. Participants’ knowledge, perceptions, and practices about nutritional intake, experiences, and expectations when accessing nutritional support were explored. Four nutrition-related themes emerged: (a) the experiences and perceptions of persons with tuberculosis and their caregivers, explained by their understanding of the importance of adequate nutrition and TB cures; (b) changes in food practices, explained by protein food adoption, alongside food insecurity experienced by those in poverty; (c) Direct Benefit Transfer (DBT)-related issues, explained by insufficiency and access-related gaps; and (d) preferred choices for nutrition support delivery, explained by less preference towards the involvement of intermediaries and a public distribution system alongside preference for the provision of nutrition through treatment facilities. Our findings underscore the importance of the provision of protein-rich food and an increase in financial support based on needs assessments. Mitigating the linkage and access gaps in DBT is needed. The delivery of ready-to-consume food through tuberculosis treatment facilities could be prioritized.